Pinsent Masons advises NanoTemper in acquisition of SAW Instruments

12 Dec 2014 | 04:28 pm |

International law firm Pinsent Masons advised NanoTemper Technologies GmbH in its recent acquisition of SAW Instruments GmbH (Bonn, Germany).
By acquiring SAW Instruments and their proprietary Surface Acoustic Wave technology, NanoTemper expands its portfolio by an additional methodology for biomolecular interaction analysis.
The Pinsent Masons team was led by corporate partner, Tobias Rodehau, aligned by Dr. Florian Anselm, Legal Director, Olivia Irrgang and Marina Arntzen.

NanoTemper Technologies GmbH
NanoTemper Technologies, founded in 2008, is a globally operating high-tech company that develops, produces and markets instruments for biomolecular analytics. NanoTemper's proprietary technology MicroScale Thermophoresis (MST) allows identifying and developing drug candidates and enables customers to test the drugs' potency quickly and effectively.

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

Pinsent Masons advises on commercial close of four new dialysis clinics in Uzbekistan

Multinational law firm Pinsent Masons has advised on the commercial close of four dialysis centres – a pathfinder public private partnership (PPP) implemented in Uzbekistan.

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts